Longitudinal Study of the Clinical and Haematological Cause of Women With Antiphospholipid Antibodies.

This study is being done to see if there are any long term health related issues in women with APA and recurrent miscarriages.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Antiphospholipid Syndrome Autoimmune Diseases Immune System Diseases

Sex eligibility

Female

Study type

Observational

Primary location

St. Mary's Hospital

London, W2 1NY, United Kingdom

About this study

The association between APA and thrombosis is well documented. Both LA and ACA are often detected in individuals with SLE but there is no prospective data on the risk of thrombosis in women who present with recurrent miscarriages in association with APA. This study should significantly advance medical knowledge of the natural history of primary antiphospholipid syndrome (PAPS) which is essential to enable optimal management of relatively young women who may be at risk of complications, some of which are potentially life threatening.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Antiphospholipid syndrome History of recurrent miscarriages

Exclusion criteria

Previous thromboembolic disease

Sponsors and collaborators

Lead sponsor

Imperial College London

Other

Registry information

Official study title

Longitudinal Study of the Clinical and Haematological Cause of Women With Antiphospholipid Antibodies in Women Presenting as Recurrent Miscarriages.

Important dates

Study start: 1998
Primary completion: 2005
Study completion: 2005
First posted: Sep 16, 2005
Registry last updated: Aug 8, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed